Ads
related to: dupixent- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Patient Access Support
Support For Patients Today
Enroll In Dupixent MyWay
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Resources
Access Support For Patients
Download Resources Today
- FAQs
Search results
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga via Yahoo Finance· 1 day agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
Sanofi's (SNY) Dupixent Gets FDA Nod for Prurigo Nodularis
Zacks via Yahoo Finance· 2 years agoSanofi SNY and its partner Regeneron REGN recently announced that the FDA has approved their...
New drug therapy ‘highly effective’ for young children with severe eczema
Press Association News via AOL· 2 years agoA new drug therapy to treat moderate to severe eczema in young children has been shown to be “safe...
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
Benzinga via Yahoo Finance· 2 years agoASLAN Pharmaceuticals (NASDAQ: ASLN) plans to initiate a new clinical trial of eblasakimab for...
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
Benzinga via Yahoo Finance· 2 years agoThe UK's Medicines and Healthcare Regulatory Agency (MHRA) warned of some new and severe eye-related...
The Most Exciting New Advances in Managing COPD
Time via Yahoo News· 2 months agoCredit - Karl Tapales—Getty Images The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and...
Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years
Benzinga via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Phase 3 trial of Dupixent...
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis
Benzinga via Yahoo Finance· 1 year agoThe European Commission approved Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's...
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
Benzinga via Yahoo Finance· 2 years agoThe FDA approved Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Dupixent...
Pharma Stock Roundup: LLY's Alzheimer's Study Setback, FDA Updates for SNY, MRK
Zacks via Yahoo Finance· 1 year agoThis week, Eli Lilly’s LLY candidate, solanezumab, failed to prevent Alzheimer’s in a study. Merck’s...
Ads
related to: dupixent